MS Conference in Amsterdam

[Guest guest]

Last week, the 5th Joint Triennieal congress of the European and Americas

Committees for Treatment and Research in MS took place. We had heard that a

lot of top neurologists around the world would be attending this event. The

treatment of OGF for MS was discussed (the endorphin that does all the good

from taking LDN). It resulted saying:-

These results indicate that OGF has a suppressive effect on the progression

of EAE, providing a novel biological therapeutic modality for the treatment

of MS by preventing disease in the induction model group and

attenuating/reversing disease in the group treated after disease

presentation.

Here's the link to the article where I believe both Drs Zagon and McLaughlin

were present http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=138197

<http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=138197 & XNSPRACHE_ID=2

& XNKONGRESS_ID=150 & XNMASKEN_ID=900>

& XNSPRACHE_ID=2 & XNKONGRESS_ID=150 & XNMASKEN_ID=900

Jayne Crocker

LDNNow logo the one to use

www.LDNNow.com

LDNNow are a political/pressure group of individuals dedicated to getting

Low Dose Naltrexone (LDN) accepted into modern medicine and trialled for the

myriad of uses it shows benefit for.

<

Dr Steele MBE, talking

about LDN

<http://www.ipetitions.com/petition/ldnnow/> Important! Please sign our

LDN petition to the European Parliament by clicking here